Browsing by Author Lourida, E.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Jump to: Α Β Γ Δ Ε Ζ Η Θ Ι Κ Λ Μ Ν Ξ Ο Π Ρ Σ Τ Υ Φ Χ Ψ Ω
or enter first few letters:  
View Option
Showing results 1 to 13 of 13
TitleAuthor(s)Issue date
Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial metabolism, coagulation, and fibrinolysisTentolouris, N.; Boutati, E.; Karambakalis, N.; Perea, D.; Tselepis, A. D.; Tsoukala, C.; Kyriaki, D.; Lourida, E.; Anastasopoulou, I.; Karafoullidou, A.; Raptis, S. A.; Katsilambros, N.24-Nov-2015
Acute nateglinide administration in subjects with type 2 diabetes: Effects on postprandial metabolism, coagulation, and fibrinolysis (vol 15, pg 6, 2005)Tentolouris, N.; Boutati, E.; Karambakalis, N.; Perrea, D.; Tselepis, A. D.; Tsoukala, C.; Kyriaki, D.; Lourida, E.; Anastasopoulou, I.; Karafoullidou, A.; Raptis, S. A.; Katsilambros, N.24-Nov-2015
Antibody titers against various forms of oxidized LDL in patients with coronary artery disease are influenced by the LDL-associated PAF-acetylhydrolase activityPapathanasiou, A.; Lourida, E.; Tselepis, A.; Elisaf, M.; Pappas, K.; Michalis, L.; Sideris, D.; Goudevenos, J.24-Nov-2015
Autoantibody titers against various forms of modified LDL in patients with stable angina are influenced by the lipoprotein-associated phospholipase A(2) (PAF-acetylhydrolase) activity and the extent of oxidation.Papathanasiou, A.; Lourida, E.; Goudevenos, J.; Tselepis, A.24-Nov-2015
Autoantibody titers against various forms of oxidized LDL and Achilles tendon thickness evaluated by ultrasonography in hyperlipidemic patientsKiortsis, D.; Tsouli, S.; Xydis, V.; Lourida, E.; Argyropoulou, M.; Efremidis, S.; Evangelou, A.; Tselepis, A.; Elisaf, M.24-Nov-2015
Correlation of autoantibody titers against various forms of oxidized LDL with carotid intima media thickness (IMT) in hyperlipidemic patientsKiortsis, D.; Tsouli, S.; Xydis, V.; Lourida, E.; Argyropoulou, M.; Efremidis, S.; Evangelou, A.; Tselepis, A.; Elisaf, M.24-Nov-2015
Enhancement in postprandial lipaemia in patients with type 2 diabetes and microalbuminuriaStylianou, A.; Tentolouris, N.; Perrea, D.; Tselepis, A. D.; Lourida, E.; Kitsou, E.; Katsilambros, N.24-Nov-2015
High postprandial triglyceridemia in patients with type 2 diabetes and microalbuminuriaTentolouris, N.; Stylianou, A.; Lourida, E.; Perrea, D.; Kyriaki, D.; Papavasiliou, E. C.; Tselepis, A. D.; Katsilambros, N.24-Nov-2015
The levels of autoantibodies against oxidized LDL in hypercholesterolemic patients are influenced by the LDL-associated PAF-acetylhydrolase activityLourida, E.; Tsouli, S.; Kiortsis, D.; Elisaf, M.; Tselepis, A.24-Nov-2015
Lipoprotein-associated phospholipase A2 activity (LP-PLA2) is a marker of small-dense LDL particlesGazi, I.; Lourida, E.; Filippatos, T.; Tsimihodimos, V.; Saougos, V.; Elisaf, M.; Tselepis, A.24-Nov-2015
Reduced levels of HDL-associated PAF-acetylhydrolase activity in normolipidemic and dyslipidemic PON1 55LL carriersKakafika, A.; Tambaki, A.; Lourida, E.; Xenofontos, S.; Tsimihodimos, V.; Kalaitzidis, R.; Cariolou, M.; Elisaf, M.; Tselepis, A.24-Nov-2015
Trimetazidine protects low-density lipoproteins from oxidation and cultured cells exposed to H(2)O(2) from DNA damageTselepis, A.; Doulias, P.; Lourida, E.; Glantzounis, G.; Tsimoyiannis, E.; Galaris, D.24-Nov-2015
Trimetazidine protects low-density lipoproteins from oxidation and cultured cells exposed to H2O2 from DNA damageTselepis, A.; Doulias, P. T.; Lourida, E.; Glantzounis, G.; Tsimoyiannis, E.; Galaris, D.24-Nov-2015